Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Clinical trial NCT00909558 · SUSPENDED

Trial details

NCT number: NCT00909558
Sponsor: Envita Medical Center, Inc.
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Glioma Hepatocellular Cancer Squamous Cell Lung Cancer Pancreatic Cancer Colon Cancer Prostate Cancer

Start date: 2009-05-01
Primary completion: 2010-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.